Narrative Essay On Autoimmune Disorder

In early November of 2014, I was just 19 years old and could barely move—my life was falling apart. I had never felt so sick and helpless before, and I thought I was going to die. The many doctors’ visits ended me in the hospital that year. I was scared to death; and I did not know what my future would hold. Now, as I take a look in the mirror, I see myself better than before. While this journey has been tough, and I still encounter many challenges of lupus (an autoimmune disease); I am thankful for God’s blessing of having my family and friends by my side during hard times.

Over 30 million people in America suffer from this skin disease. It’s very common, especially in children. It’s a disease known as Eczema or Atopic dermatitis, it has no cure but have scientists finally found one? In July 2015 doctors might have found a cure, which would help millions that have suffered from this disease. Using six patients, the scientists made them consume a pill to aid arthritis; it helped all patients with their eczema clearing their skin completely. The arthritis drug is a significant scientific advancement because it will help cure eczema and all the children and adults who suffer from it.

Wayne is a 58-year-old male who suffers from plaque psoriasis (L40.0), along with arthritis. Daniel’s symptoms include red, rough, scaly, itchy, burning, splitting, painful plaques located especially on his hands, upper and lower extremities, head, abdomen, and back, with a BSA of 18%, as well as stiff joints. He has tried and failed various treatments including multiple topicals, lidex, clobetasol, Prednisone, eucrisa, and intralesionals, with little to no relief. Wayne works on cars and has his hands in contact with cleaning solutions, which causes increased pain and discomfort. The denial states that Wayne must have a history of failure, contraindication, or intolerance to both Humira and Enbrel. Humira and Enbrel both suppress the

Psoriasis is a constant immune system infection that for the most part influences the integumentary framework. In the United States, psoriasis is the most common immune system sicknesses, affecting around 7.5 million Americans, or 2 – 3% of the populace. Despite the fact that psoriasis can happen at any age, the mean period of onset for the first event is between 15 – 20 years, with a second crest at 55 – 60 years. While the definite reasons for psoriasis are obscure, the illness happens when a strange insusceptible reaction prompts hyperproliferation of youthful cells of the dermis and epidermis, changed cell separation, and aggravation. The invulnerable reaction connected with psoriasis is T-cell intervened. Lymphocytes will be lymphocytes, or

Brian is a 29-year-old male who suffers from plague psoriasis (L40.0). His symptoms include scaly, red, moderate in severity plaques located on his feet, hands, trunk, and scalp, in addition to plaque psoriasis he also suffers with arthritis. He experiencing sever fissuring and pain with walking and daily functioning. Brian has tried and failed various treatments including clobetasol, and keralac, both provided him with little to no relief. Otezla was denied for requiring a three-month trial of light therapy, however, he is not a candidate for light treatment due to his work schedule. Otezla was approved for moderate to severe plaque psoriasis by regulating inflammation within immune cells without said side effects or risks. By helping to

Many studies have been done exploring how a patient’s health-related quality of life is affected by having psoriasis. HRQoL has been found to be severely affected by a patient’s psoriasis (Radulski, 2013; Pg. 32). Having visible lesions on the skin can lead to self-confidence problems and self-image destruction. These visible patches can sometimes result in unwelcomed reactions of others (Lahousen et al., 2016; Pg. 78). Having been described as

Cindy is a 55-year-old female who suffers from plaque psoriasis (L40.0), along with psoriatic arthopathy. Her symptoms include severe, itchy, painful plaques on scalp and ears, along with painful joints that are swollen, and inflamed. Previously, Cindy has tried and failed various treatments including clobetasol and Taclonex, with little to no relief. Your denial indicates that Cindy is to have an inadequate response, contraindication, documented intolerance to Systemic therapy (Methotrexate, Cyclosporine, or acitretin), or UVA/ UVB phototherapy. Systemic medications are also too much of a risk for Cindy because they have adverse side effects, which can also be extremely fatal. She is also not a candidate for Phototherapy due to the severe

Psoriasis is known as erythematous papules and plaques on the elbows, knees and scalp. It is very common in both men and women, and can begin at any age. Pregnant women have often worried about whether their condition would affect their pregnancy or cause birth defects, but the effects are unknown due to the fact that all pregnancies are different. A study was conducted that showed 55% of women said their psoriasis improved during pregnancy, 21% said there was no change, and 23% said their case worsened while they were pregnant. Although the effects are unknown, we do know that the disease doesn’t affect fertility or reproductive organs and that c-section wounds can cause infection and a slower healing process. Yang, Chen, Chen, and Lin conducted

It is important that one is informed about my topic because anyone could have Psoriasis without knowing and this can help one see whether or not they have the symptoms of Psoriasis. It is important because it is a genetic disease that is commonly found in people and that more people should know about. Psoriasis is a condition that can change your skin because it can make one’s skin dry and it makes the texture different. This skin condition is important because many people have it and it can be treated with the right medication that is needed to help prevent it from getting worse than it already

I had a lot of stress because when I was younger I had very bad psoriasis but I was very consistent and stayed on top of taking my medicine but even with that I still had some psoriasis left. I wasn’t able to wear the clothing that I wear now but I used to always have to cover up and sometimes even when it was dead hot in the summer I would be covered up because I didn’t want to be picked on for my psoriasis. There were times where I couldn’t always be covered up and people would either ask me rude questions about it or just make fun of me not knowing that its something that is out of my control. Which made it hard to make

Psoriasis is a skin disease and was first perceived as a distinct disease as early as 1808 [39]. The name derives from the Greek “psora” meaning “to itch” [40]. The patients suffer impaired quality of life similar to or worse than patients with other chronic diseases such as ischemic heart disease and diabetes [41]. Over the past 20 years, understanding of the disease mechanisms has most significantly and several effective development of drugs for treatments to be developed. However, we still lack a cure for this common and enigmatic disease and many patients experience significant side effects including skin cancers in non-lesional skin, abnormal renal function and liver abnormalities. It is anticipated that the identification of genes or antigens responsible for the occurrence of psoriasis will increase our understanding of its nature and make it possible to design drugs to increase patient compliance and safety and to reduce medical costs.

Psoriasis is an ongoing skin condition, where the skin develops patches of itchy, red, scaly skin. Chances are, if you develop psoriasis, family members also have/had the condition, as there is a genetic association for psoriasis.

According to the American Academy of Dermatology, about 7.5 million Americans are currently being affected by psoriasis. Psoriasis is a disease in which cells are inflamed, causing them to vastly multiply, which then causes the skin to become red, patched, and raise above normal. Rather than taking 28-30 days to regenerate, the cells of a psoriasis patient multiplies within very few days. With this, the old, dead cells pile up, causing the redness and raise of the skin. This disease generally affects the patient’s popliteal, olecranal, palm, sole, lumbar, face, and inguinal regions. Studies show that the more surface area of the body that is covered by psoriasis, the greater the risk of death for the patient. Patients with 10% or more of

This dermatologic journey started in my early years of life, when all my vacations were dermatology meetings. My parents used to take my sister and I to every conference, using them as excuse so we could travel the world. Furthermore, the fact that I had to work on my father’s slides because of his inexperience in the use of PowerPoint made me develop a blossoming passion for this profession. Following years of high school, medical school, and working experience have brought me to this point, where I am trying to show off, desperately desiring to be considered as a candidate for your program.

Psoriasis is a common (2% to 3% of the population), benign and life-long chronic inflammatory skin condition involving the skin, scalp, nails and sometimes joints (Mahajan & Handa, 2013). It is genetically transmitted with a 30% increased risk of first-degree relatives developing psoriasis and a 72% concordance between monozygotic twins (Habif, 2010; Mahajan & Handa, 2013). A genetic and hereditary (autosomal dominant with 60% penetration) basis for psoriasis is supported by the presence of certain major histocompatibility complex antigens, HLAs A1, B13, B17, B37, DR7, in certain psoriasis patients (Mahajan & Handa, 2013). Genetically, two forms of psoriasis [Type I and II] have been proposed: HLA-Cw6, the strongest of the histocompatibility complexes, is found in approximately 85% of Type I (hereditary, age onset of 16 to 22 years, follows an irregular course before generalizing) and in approximately 15% of Type II (sporadic, peak incidence of 60 years old) psoriasis patients (Mahajan & Handa, 2013).